Fig. 3From: The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillationSafety endpoints in the DOAC group compared with the VKA group. Abbreviation: DOAC direct oral anticoagulants, VKA vitamin K antagonistsBack to article page